Ambulatory infusion devices in the continuing care of patients with advanced diseases

Journal of Pain and Symptom Management

Volumn 5, Issue 5, 1990, Pages 287-296

  Bruera, Eduardo ^a  

^a Edmonton General Hospital   (Canada)

Author keywords

cancer; infusion; narcotics; pain; parenteral; Portable pump; subcutaneous

Indexed keywords

DIAMORPHINE; HYDROMORPHONE; MORPHINE;

ANALGESIA; ARTICLE; CANCER PAIN; EDUCATION; FAMILY; HOME CARE; HUMAN; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; ORGANIZATION AND MANAGEMENT; SUBCUTANEOUS DRUG ADMINISTRATION; VOCATIONAL EDUCATION;

ANALGESIA, PATIENT-CONTROLLED; FLUID THERAPY; HOME CARE SERVICES; HUMAN; INFUSION PUMPS; PATIENT EDUCATION; TERMINAL CARE;

EID: 0025037377     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(90)90045-L     Document Type: Article

References (42)

1. The treatment of cancer pain
2. Subcutaneous administration of narcotics
3. Management of cancer pain with parenteral medication
4. Intravenous morphine infusion for chronic pain
5. IV infusion of opioids for cancer pain: clinical review and guidelines for use
6. Safety and efficacy of continuous intravenous morphine for severe cancer pain
7. Morphine controlled trial of different methods of administration of post-operative pain relief
8. Implantable devices for chemotherapy: access and delivery
9. Totally implanted venous and arterial access system to replace external catheters in cancer treatment
10. The use of the subcutaneous route for the administration of narcotics in patients with cancer pain
11. Continuous SC infusion of narcotics using a portable disposable device in patients with advanced cancer
12. The importance of continuous SC morphine administration for cancer pain control
13. Serum morphine levels: a comparison between continuous subcutaneous and intravenous infusion in post-operative patients
14. Analgesic plasma concentrations of morphine in children with terminal malignancy receiving a continuous subcutaneous infusion of morphine to control severe pain
15. Continuous subcutaneous infusion of morphine for post-operative pain relief
16. Continuous subcutaneous infusion of morphine
17. Analgesia in terminal malignant disease [letter]
18. Continuous subcutaneous analgesia for terminal care at home [Letter]
19. Local toxicity during subcutaneous infusion of narcotics: a prospective study
20. Continuous subcutaneous infusion of morphine for post-operative pain relief
21. Continuous narcotic infusion with patient-controlled analgesia for chronic cancer pain in out-patients
22. Continuous infusion of opioid drugs in the treatment of cancer pain: guidelines for use
23. Continuous SC infusion of narcotics for the treatment of cancer pain: an update
24. Delirium and severe sedation in patients with terminal cancer
25. Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain
26. Continuous subcutaneous infusion of narcotics using a portable disposable pump
27. The Uppsala experience of patient-controlled analgesia
28. The Oxford system of patient-controlled analgesia
29. Cancer pain
30. Nutrition in patients with advanced cancer: an update and review of our experience
31. Local toxicity during the subcutaneous infusion of narcotics (SCIN): a prospective study
32. Metoclopramide infusion with a disposable portable pump
33. Continuous subcutaneous (SC) infusion of metoclopramide (MCP) using a plastic disposable infusor for the treatment of chemotherapy-induced emesis
34. Continuous SC infusion of metoclopramide plus dexamethasone in the control of cisplatinum-induced emesis
35. Continuous SC infusion of metoclopramide for treatment of narcotic bowel syndrome
36. Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide
37. Phase I and pharmacokinetics of BRL 43694: effective control of cisplatin-induced emesis
38. Dose-range evaluation of BMY-25801, a non-dopaminergic antiemetic
39. Hypodermoclysis for symptom control in terminal care
40. Administration of potassium by subcutaneous infusion in elderly patients
41. Subcutaneous infusions in the elderly